Latest Insider Transactions at In8 Bio, Inc. (INAB)
This section provides a real-time view of insider transactions for In8 Bio, Inc. (INAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IN8BIO, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IN8BIO, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 04
2024
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
126,582
+4.73%
|
-
|
|
Oct 04
2024
|
Peter C. Brandt |
BUY
Grant, award, or other acquisition
|
Direct |
253,164
+32.85%
|
-
|
|
Oct 04
2024
|
Alan S. Roemer |
BUY
Grant, award, or other acquisition
|
Direct |
126,582
+30.75%
|
-
|
|
Oct 04
2024
|
Patrick Mc Call CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+32.71%
|
-
|
|
Oct 04
2024
|
Kate Rochlin Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,316
+37.13%
|
-
|
|
Dec 13
2023
|
Alan S. Roemer |
BUY
Grant, award, or other acquisition
|
Direct |
102,459
+39.27%
|
-
|
|
Dec 13
2023
|
Corinne Epperly |
BUY
Grant, award, or other acquisition
|
Direct |
81,967
+50.0%
|
-
|
|
Dec 13
2023
|
Jeremy R. Graff |
BUY
Grant, award, or other acquisition
|
Direct |
2,049
+31.05%
|
-
|
|
Dec 13
2023
|
Trishna Goswami Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,098
+37.85%
|
-
|
|
Dec 13
2023
|
Kate Rochlin Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,295
+41.19%
|
-
|
|
Dec 13
2023
|
Patrick Mc Call CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,492
+43.37%
|
-
|
|
Dec 13
2023
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
81,967
+3.27%
|
-
|
|
Dec 13
2023
|
Peter C. Brandt |
BUY
Grant, award, or other acquisition
|
Direct |
81,967
+23.66%
|
-
|
|
Dec 13
2023
|
Lawrence Lamb EVP and CSO |
BUY
Grant, award, or other acquisition
|
Direct |
1,639
+1.59%
|
-
|
|
Sep 13
2023
|
Jeremy R. Graff |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$0
$0.95 P/Share
|
|
Aug 25
2023
|
Patrick Mc Call CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
1,000
+13.77%
|
$1,000
$1.03 P/Share
|
|
Aug 24
2023
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
23,800
+1.01%
|
$23,800
$1.05 P/Share
|
|
Jul 28
2023
|
Emily Fairbairn |
SELL
Other acquisition or disposition
|
Indirect |
4,111,958
-100.0%
|
-
|
|
Dec 12
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
75,001
+1.51%
|
$150,002
$2.48 P/Share
|
|
Dec 12
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
75,001
+1.51%
|
$150,002
$2.48 P/Share
|
|
Sep 28
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.52%
|
$50,000
$2.02 P/Share
|
|
Sep 28
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.52%
|
$50,000
$2.02 P/Share
|
|
Aug 29
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.83%
|
$80,000
$2.02 P/Share
|
|
Aug 29
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.83%
|
$80,000
$2.02 P/Share
|
|
Aug 26
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,214
+0.23%
|
$22,428
$2.01 P/Share
|
|
Aug 26
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,214
+0.23%
|
$22,428
$2.01 P/Share
|
|
Aug 17
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.04%
|
$50,000
$1.93 P/Share
|
|
Aug 17
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.04%
|
$50,000
$1.93 P/Share
|
|
Aug 16
2022
|
Kate Rochlin Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,263
+50.0%
|
$5,263
$1.9 P/Share
|
|
Aug 16
2022
|
Patrick Mc Call CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,263
+50.0%
|
$5,263
$1.9 P/Share
|
|
Aug 16
2022
|
Lawrence Lamb EVP and CSO |
BUY
Open market or private purchase
|
Direct |
526
+0.52%
|
$526
$1.9 P/Share
|
|
Aug 16
2022
|
Alan S. Roemer |
BUY
Open market or private purchase
|
Direct |
26,315
+31.97%
|
$26,315
$1.9 P/Share
|
|
Aug 16
2022
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
26,315
+1.12%
|
$26,315
$1.9 P/Share
|
|
Aug 16
2022
|
Luba Greenwood |
BUY
Open market or private purchase
|
Direct |
526
+6.3%
|
$526
$1.9 P/Share
|
|
Aug 16
2022
|
Trishna Goswami Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,631
+50.0%
|
$2,631
$1.9 P/Share
|
|
Aug 16
2022
|
Emily Fairbairn |
BUY
Open market or private purchase
|
Indirect |
789,473
+16.11%
|
$789,473
$1.9 P/Share
|
|
Aug 16
2022
|
Peter C. Brandt |
BUY
Open market or private purchase
|
Direct |
105,263
+36.58%
|
$105,263
$1.9 P/Share
|
|
Aug 16
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,773,684
+35.02%
|
$1,773,684
$1.9 P/Share
|
|
Aug 16
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,773,684
+35.02%
|
$1,773,684
$1.9 P/Share
|
|
May 05
2022
|
Lawrence Lamb EVP and CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,204
+20.9%
|
$26,204
$1.07 P/Share
|
|
Aug 03
2021
|
Emily Fairbairn |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.92%
|
$1,000,000
$10.0 P/Share
|
|
Aug 03
2021
|
Emily Fairbairn |
BUY
Conversion of derivative security
|
Indirect |
3,333,315
+49.22%
|
-
|
|
Aug 03
2021
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,625,102
+50.0%
|
-
|
|
Aug 03
2021
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Indirect |
3,070
+4.04%
|
-
|
|
Aug 03
2021
|
Leslie W. Kreis > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,625,102
+50.0%
|
-
|